Bank of America Corporation 13D and 13G filings for Adverum Biotechnologies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 7:34 pm Sale |
2023-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
BANK OF AMERICA CORP BAC |
442,590 4.400% |
-116,600 (-20.85%) |
Filing |
| 2023-02-14 07:55 am Purchase |
2022-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
BANK OF AMERICA CORP BAC |
559,190 5.600% |
559,190 (New Position) |
Filing |